• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Three Rivers Diagnostics

anonymous

Guest
Does anyone have any experience with this lab? The CEO is pretty aggressive. Recruiting heavily. Toxicology mostly. Are any of these tox/molecular labs, that have only been open a few years worth working for? They say they have in network contracts, but I believe mostly Medicaid.
 




Does anyone have any experience with this lab? The CEO is pretty aggressive. Recruiting heavily. Toxicology mostly. Are any of these tox/molecular labs, that have only been open a few years worth working for? They say they have in network contracts, but I believe mostly Medicaid.

They suck. Worked there for a year. Ended up leaving because providers realized their results were inaccurate.